TrialAmerican journal of hematology2020

Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy.

Jacqueline S Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.